OBJECTIVE Even in high-risk trials pertaining to transcatheter aortic valve replacement (TAVR), patients with end-stage liver disease (ESLD) have been under-represented. We sought to study this population group from a large national United States population database. METHODS We used National Inpatient Sample (NIS) database from January 2005 to…[Read more]